Literature DB >> 2183584

Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study.

U Berger1, A Khaghani, A Pomerance, M H Yacoub, R C Coombes.   

Abstract

Estrogen and progesterone receptors were demonstrated immunocytochemically in the lung tissue of two cases of pulmonary lymphangioleiomyomatosis. In one case both receptors were localized in the proliferative smooth muscle nodules and diffusely in the interstitial tissue in close proximity to the muscle. The pulmonary tissue in the other case contained the estrogen receptor only. The authors conclude that the response to hormonal treatment seen in this disease might be optimized in the future by monitoring for the presence of steroid hormone receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183584     DOI: 10.1093/ajcp/93.5.609

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  23 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Lymphangioleiomyomatosis.

Authors:  Francis X McCormack
Journal:  MedGenMed       Date:  2006-01-18

3.  Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.

Authors:  Yang Sun; Erik Zhang; Taotao Lao; Ana M Pereira; Chenggang Li; Li Xiong; Tasha Morrison; Kathleen J Haley; Xiaobo Zhou; Jane J Yu
Journal:  Horm Cancer       Date:  2014-07-29       Impact factor: 3.869

Review 4.  Unusual causes of pneumothorax.

Authors:  Daniel R Ouellette; Scott Parrish; Robert F Browning; J Francis Turner; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 5.  Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Authors:  Hen Prizant; Stephen R Hammes
Journal:  Endocrinology       Date:  2016-07-13       Impact factor: 4.736

6.  Lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Wendy K Steagall; Joel Moss
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2009

Review 7.  Unconventional Estrogen Signaling in Health and Disease.

Authors:  Christina L Faltas; Kira A LeBron; Marina K Holz
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

Review 8.  Lymphangioleiomyomatosis and TSC2-/- cells.

Authors:  Thomas N Darling; Gustavo Pacheco-Rodriguez; Alfredo Gorio; Elena Lesma; Cheryl Walker; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

9.  The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

Authors:  Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

10.  Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen--a case report.

Authors:  M Klein; O Krieger; R Ruckser; A Rosen; R Waldner; P Preis; A Beck
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.